Dramamine Orange Tablet, Chewable
NDC Package 63029-902-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Dramamine Orange (dimenhydrinate) tablets is dimenhydrinate is an antihistamine used to prevent and treat nausea, vomiting and dizziness caused by motion sickness when medication cannot be given by mouth. This formulation utilizes a tablet, chewable delivery system. Marketed by Medtech Products Inc., this product is identified by NDC 63029-902 and is authorized under FDA application M009.

Identification & Billing

NDC Package Code
63029-902-01
Package Description
1 BLISTER PACK in 1 BOX / 8 TABLET, CHEWABLE in 1 BLISTER PACK
Product Code
11-Digit Billing Format
63029090201
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Dramamine Orange
Non-Proprietary Name
Dimenhydrinate
Substance Name
Dimenhydrinate
Dosage Form
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Dimenhydrinate is an antihistamine used to prevent and treat nausea, vomiting and dizziness caused by motion sickness when medication cannot be given by mouth. Dimenhydrinate injection should not be used in newborns because of an increased risk of side effects.

Regulatory & Marketing

Labeler Name
Medtech Products Inc.
Product Type
Human Otc Drug
FDA Application #
M009
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-15-2012
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (63029-902). Click a package code to view its specific billing and regulatory data.

2 TABLET, CHEWABLE in 1 POUCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63029-902-01 identifies a specific commercial package of 1 blister pack in 1 box / 8 tablet, chewable in 1 blister pack of Dramamine Orange, a human over the counter drug labeled by Medtech Products Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This tablet, chewable is formulated for oral use and contains dimenhydrinate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medtech Products Inc. on January 15, 2012. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Dimenhydrinate is an antihistamine used to prevent and treat nausea, vomiting and dizziness caused by motion sickness when medication cannot be given by mouth. Dimenhydrinate injection should not be used in newborns because of an increased risk of side effects.

How is this Medtech Products Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63029090201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63029-902-01
11-Digit CMS (5-4-2)
63029-0902-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.